The November, 2010, issue of The Atlantic has a stunning article about the damning ineffectiveness of medical studies. Damning.
I recently noted an article revealing shoddy studies at the University of Minnesota, a school for which I have very high regard. In the field of medicine, it seems that the profit-motive has gone toe-to-toe with the Hippocratic Oath... the Oath may not be knocked out, but medical studies are gamed by the companies pushing drugs and submitted to privatized, rubber stamp Institutional Review Boards before being published in peer-reviewed journals. The whole enterprise is shameful.
As profiled by The Atlantic, Dr. John Ioannidis is revealing just how screwed up the system is and how it leads to a crapshoot for Doctors who cannot know the best course of action for their patients.
He’s what’s known as a meta-researcher, and he’s become one of the world’s foremost experts on the credibility of medical research. He and his team have shown, again and again, and in many different ways, that much of what biomedical researchers conclude in published studies—conclusions that doctors keep in mind when they prescribe antibiotics or blood-pressure medication, or when they advise us to consume more fiber or less meat, or when they recommend surgery for heart disease or back pain—is misleading, exaggerated, and often flat-out wrong. He charges that as much as 90 percent of the published medical information that doctors rely on is flawed. His work has been widely accepted by the medical community; it has been published in the field’s top journals, where it is heavily cited; and he is a big draw at conferences. Given this exposure, and the fact that his work broadly targets everyone else’s work in medicine, as well as everything that physicians do and all the health advice we get, Ioannidis may be one of the most influential scientists alive. Yet for all his influence, he worries that the field of medical research is so pervasively flawed, and so riddled with conflicts of interest, that it might be chronically resistant to change—or even to publicly admitting that there’s a problem.
Read the full article - I cannot do it justice.
What I think about is conversations in Public Policy grad school, when we discussed how to structure the necessary trials for new medicines. Should it be controlled by the companies who stand to gain from approving the treatments? The knee-jerk reaction is absolutely not, for obvious reasons. But the main alternative would be for tax dollars to pay for these studies -- amounting to a massive taxpayer subsidy for costs that should be incurred by those developing the drugs. Perhaps a solution where the drug studies are funded by those who stand to profit from the medicine but designed and controlled by independent labs.
I'm not enough of an expert to know the best structure for solving this problem, but the pendulum has clearly swung far too far in favor of the private sector companies producing these treatments. Washington DC's obsession with the private sector solving every problem, no matter how poorly suited to markets to solve, has clearly set back medical science.
Recent comments
2 weeks 4 days ago
2 weeks 5 days ago
2 weeks 5 days ago
2 weeks 5 days ago
3 weeks 10 hours ago
3 weeks 10 hours ago
5 weeks 5 days ago
5 weeks 6 days ago
5 weeks 6 days ago
11 weeks 3 days ago